Simulation-based validation of the p53 transcriptional activity with hybrid functional Petri net

In Silico Biology

Volumn 6, Issue 1-2, 2006, Pages 1-13

  Doi, Atsushi ^a   Nagasaki, Masao ^a   Matsuno, Hiroshi ^b   Miyano, Satoru ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b YAMAGUCHI UNIVERSITY   (Japan)

Author keywords

Biological pathway; Hybrid functional Petri net; p53; Simulation

Indexed keywords

PROTEIN MDM2; PROTEIN P19ARF; PROTEIN P53; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BIOINFORMATICS; COMPUTER MODEL; COMPUTER NETWORK; COMPUTER SIMULATION; FUNCTIONAL PROTEOMICS; MOLECULAR INTERACTION; PROTEIN DATABASE; PROTEIN FUNCTION; PROTEIN INTERACTION; TRANSCRIPTION REGULATION; VALIDATION PROCESS;

ANIMALS; BCL-2-ASSOCIATED X PROTEIN; COMPUTER SIMULATION; HUMANS; MODELS, BIOLOGICAL; PROTO-ONCOGENE PROTEINS C-MDM2; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC; TUMOR SUPPRESSOR PROTEIN P14ARF; TUMOR SUPPRESSOR PROTEIN P53;

EID: 33745213569     PISSN: 13866338     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Alla, H. and David, R. (1998). Continuous and hybrid Petri nets. J. Circuits, Systems, and Computers 8, 159-188.
2. Barak, Y., Juven, T., Haffner, R. and Oren, M. (1993). mdm2 expression is induced by wild type p53 activity. EMBO J. 12, 461-468.
3. Doi, A., Nagasaki, M., Fujita, S., Matsuno, H. and Miyano, S. (2003). Genomic Object Net: II. Modelling biopathways by hybrid functional Petri net with extension. Appl. Bioinformatics 2, 185-188.
4. Doi, A., Fujita, S., Matsuno, H., Nagasaki, M. and Miyano, S. (2004). Constructing biological pathway models with hybrid functional Petri net. In Silico Biol. 4, 0023.
5. el-Deiry W. S. (1998). Regulation of p53 downstream genes. Semin. Cancer Biol. 8, 345-357.
6. Fujita, S., Matsui, M., Matsuno, H. and Miyano, S. (2004). Modeling and simulation of fission yeast cell cycle on hybrid functional Petri net. IEICE Trans. Fundamentals E87-A, 2919-2928.
7. Honda, R., Tanaka, H. and Yasuda, H. (1997). Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53. FEBS Lett. 420, 25-27.
8. Iwakuma, T. and Lozano, G. (2003). MDM2, An Introduction. Mol. Cancer. Res. 1, 993-1000.
9. Kamijo, T., Weber, J. D., Zambetti, G., Zindy, F., Roussel, M. F. and Sherr, C. J. (1998). Functional and physical interactions of the ARF tumor suppressor with p53 and Mdm2. Proc. Natl. Acad. Sci. USA 95, 8292-8297.
10. Kanehisa, M. and Goto, S. (2000). KEGG: Kyoto Encyclopedia of Genes and Genomes. Nucleic Acids Res. 28, 27-30.
11. Kohn, K. W. (1999). Molecular interaction map of the mammalian cell cycle control and DNA repair systems. Mol. Biol. Cell. 10, 2703-2734.
12. Krull, M., Voss, N., Choi, C., Pistor, S., Potapov, A. and Wingender, E. (2003). TRANSPATH®: An integrated database on signal transduction and a tool for array analysis. Nucleic Acids Res. 31, 97-100.
13. Matsui, M., Fujita, S., Suzuki, S., Matsuno, H. and Miyano, S. (2004). Simulated cell division processes of the xenopus cell cycle pathway by Genomic Object Net. J. Integrative Bioinfomatics, 0003.
14. Matsuno, H., Doi, A., Nagasaki, M. and Miyano, S. (2000). Hybrid Petri net representation of gene regulatory network. Pac. Symp. Biocomput. 5, 338-349.
15. Matsuno, H., Murakami, R., Yamane, R., Yamasaki, N., Fujita, S., Yoshimori, H. and Miyano, S. (2003a). Boundary formation by notch signaling in Drosophila multicellular systems: Experimental observations and a gene network modeling by Genomic Object Net. Pac. Symp. Biocomput. 8, 152-163.
16. Matsuno, H., Tanaka, Y., Aoshima, H., Doi, A., Matsui, M. and Miyano, S. (2003b). Biopathways representation and simulation on hybrid functional Petri net. In Silico Biol. 3, 0032.
17. Miyashita, T. and Reed, J. C. (1995). Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 80, 293-299.
18. Nagasaki, M., Doi, A., Matsuno, H. and Miyano, S. (2003). Genomic Object Net: I. A platform for modeling and simulating biopathways. Appl. Bioinformatics 2, 181-184.
19. Nagasaki, M., Doi, A., Matsuno, H. and Miyano, S. (2004). Integrating biopathway databases for large-scale modeling and simulation. In: Conferences in Research and Practice in Information Technology, Vol. 29 - Bioinformatics, Chen, Y.-P. P. (ed.), Australian Computer Society, pp. 43-52.
20. Oliner, J. D., Pietenpol, J. A., Thiagalingam, S., Gyuris, J., Kinzler, K. W. and Vogelstein, B. (1993). Oncoprotein MDM2 conceals the activation domain of tumor suppressor p53. Nature 362, 857-860.
21. Arf interacts with MDM2 and neutralizes MDM2's inhibition of p53. Cell 92, 713-723.
22. ARF stabilizes p53 by blocking nucleo-cytoplasmic shuttling of Mdm2. Proc. Natl. Acad. Sci. USA 96, 6937-6941.
23. Zhang, Y., Xiong, Y. and Yarbrough, W. G. (1998). ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4α locus deletion impairs both the Rb and p53 tumor suppression pathways. Cell 92, 725-734.
24. Zhang, Y. and Xiong, Y. (1999). Mutation in human ARF exon 2 disrupt its nucleolar localization and impair its ability to block nuclear export of MDM2 and p53. Mol. Cell 3, 579-591.
25. Zhang, Y. and Xiong, Y. (2001). Control of p53 ubiquitination and nuclear export by MDM2 and ARF. Cell Growth Differ. 12, 175-186.